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Mediates Parasite Survival during Nutrient Stress
Yi-Pei Chen,a,b Olivia Twu,a,b* Patricia J. Johnsona,b
aMolecular Biology Institute, University of California, Los Angeles, Los Angeles, California, USA
bDepartment of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los
Angeles, California, USA
ABSTRACT Trichomonas vaginalis is responsible for the most prevalent non-viral
sexually transmitted disease worldwide, and yet the mechanisms used by this para-
site to establish and maintain infection are poorly understood. We previously identi-
fied a T. vaginalis homologue (TvMIF) of a human cytokine, human macrophage mi-
gration inhibitory factor (huMIF). TvMIF mimics huMIF’s role in increasing cell growth
and inhibiting apoptosis in human host cells. To interrogate a role of TvMIF in para-
site survival during infection, we asked whether overexpression of TvMIF (TvMIF-OE)
confers an advantage to the parasite under nutrient stress conditions by comparing
the survival of TvMIF-OE parasites to that of empty vector (EV) parasites. We found
that under conditions of serum starvation, overexpression of TvMIF resulted in in-
creased parasite survival. Serum-starved parasites secrete 2.5-fold more intrinsic
TvMIF than unstarved parasites, stimulating autocrine and paracrine signaling. Simi-
larly, we observed that addition of recombinant TvMIF increased the survival of the
parasites in the absence of serum. Recombinant huMIF likewise increased the para-
site survival in the absence of serum, indicating that the parasite may use this host
survival factor to resist its own death. Moreover, TvMIF-OE parasites were found to
undergo significantly less apoptosis and reactive oxygen species (ROS) generation
under conditions of serum starvation, consistent with increased survival being the
result of blocking ROS-induced apoptosis. These studies demonstrated that a para-
sitic MIF enhances survival under adverse conditions and defined TvMIF and huMIF
as conserved survival factors that exhibit cross talk in host-pathogen interactions.
IMPORTANCE Macrophage migration inhibitory factor (MIF) is a conserved protein
found in most eukaryotes which has been well characterized in mammals but poorly
studied in other eukaryotes. The limited analyses of MIF proteins found in unicellular
eukaryotes have focused exclusively on the effect of parasitic MIF on the mamma-
lian host. This was the first study to assess the function of a parasite MIF in parasite
biology. We demonstrate that the Trichomonas vaginalis MIF functions to suppress
cell death induced by apoptosis, thereby enhancing parasite survival under adverse
conditions. Our research reveals a conserved survival mechanism, shared by a para-
site and its host, and indicates a role for a conserved protein in mediating cross talk
in host-pathogen interactions.
KEYWORDS Trichomonas vaginalis, apoptosis, macrophage migration inhibitory
factor, nutrient starvation
Trichomonas vaginalis, an extracellular unicellular parasite, causes the most commonnon-viral sexually transmitted infection in the world (1) but has been long ne-
glected. Thus, the mechanisms that drive parasite pathogenesis and the disease
epidemiology are poorly understood (2). However, this is changing as more molecular
and genetic tools for analyses are developed (3, 4). The majority of T. vaginalis
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infections are asymptomatic. When they are symptomatic, the manifestations of infec-
tion vary greatly and may include inflammation of the urogenital tract, preterm
delivery, and increased chances of HIV co-infection (5, 6). The factors that determine
how the parasite maintains the infection in the vaginal microenvironment, where the
nutrients, hormones, and pH are constantly changing, remain largely unknown (7–9).
Macrophage migration inhibitory factor (MIF) is a highly conserved eukaryotic
protein found across unicellular protists, plants, arthropods, and mammals (10–13).
Human MIF (huMIF) has been widely studied and is known to play essential roles in cell
growth, survival and in cancer growth in humans (14–16). In our previous study, we
reported that T. vaginalis shares a homologous protein (TvMIF) with the human host
and that TvMIF can activate the same survival pathways as huMIF in human cells (17).
MIF homologues found in other eukaryotic parasites are known to modulate the host
immune system and to activate huMIF pathways (10, 18–21). Although the effects of
parasite-derived MIFs from parasites on host cells have been studied, the role of MIF in
parasites and non-mammalian systems is poorly understood.
T. vaginalis and other parasitic protists share certain apoptotic phenotypes with
mammalian systems such as DNA fragmentation and phosphatidylserine exposure
(22–25). However, no factor that either stimulates or suppresses apoptosis in these
divergent, unicellular eukaryotes has yet been identified. In this report, we describe the
anti-apoptotic effect caused by TvMIF, a conserved eukaryotic protein, and reveal
similarities between this protein and its mammalian homologue. We also provide
evidence that T. vaginalis is able to exploit huMIF to enhance its survival during nutrient
starvation. These studies uncovered a highly conserved eukaryotic protein used by a
parasite and its host to enhance survival.
RESULTS
T. vaginalis MIF (TvMIF) enhances survival of the parasites under conditions of
nutrient stress. We have previously shown that the homologue of huMIF in the
parasite T. vaginalis (TvMIF) can induce the growth and activation of anti-apoptotic
pathways in human host cells (17). To investigate whether TvMIF can perform a similar
function and hence enhance the survival of the parasite under adverse conditions, we
have studied the role of TvMIF in parasite survival under conditions of nutrient and
density stress. T. vaginalis is typically grown in Diamond’s media supplemented with
serum (26). The parasite will not grow in the absence of serum as it provides lipids,
precursors of nucleotides, and amino acids required for parasite survival (26, 27).
Parasites also cease to swim and die within hours after reaching a density of 5 
106 cells/ml in Diamond’s media supplemented with serum (27). As a first step toward
determining whether TvMIF plays a role in parasite survival, we compared the survival
rates of parasites transfected with (28) and overexpressing TvMIF (TvMIF-OE) with those
transfected with an empty vector (EV). Immunoblotting confirmed that expression of
TvMIF in TvMIF-OE parasites is approximately 17-fold greater than in EV control
parasites (see Fig. S1 in the supplemental material).
Fluorescence-activated cell sorter (FACS) analyses of living cells assessed using
Zombie Red viability dye to compare TvMIF-OE and EV parasites were conducted using
parasites grown in serum-free media or at a high density. We found that TvMIF-OE
parasites survived significantly better than EV parasites in serum-free media after 8 h of
incubation and that this survival phenotype became more pronounced after 24 to 32 h
of starvation (Fig. 1A; see also Fig. S2). Comparison of the survival rates of TvMIF-OE and
EV parasites at densities as high as 107 cells/ml or 2  107 cells/ml also revealed the
death of a significantly higher proportion of EV parasites than of TvMIF-OE parasites at
4 and 8 h after they were subjected to density stress (Fig. 1B). When grown in regular
media supplemented with serum, EV and TvMIF-OE had similar growth rates (Fig. S3),
demonstrating that TvMIF promotes parasite survival under adverse conditions.
TvMIF is secreted as both a free soluble protein and an exosomal protein. We
have previously demonstrated that T. vaginalis secretes small vesicles called exosomes
(29, 30) and that TvMIF is found in the exosomal proteome (31). As the survival
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pathways activated by huMIF require a secreted soluble form of the protein (16, 32), we
examined both the exosomal fractions (Exo) and the non-exosomal soluble fractions
(NESF) secreted by the parasite for TvMIF using a Vivaflow crossflow cassette and an
ultracentrifugation-based method (Fig. 2A). Parasites grown overnight were collected
and then incubated in phosphate-buffered saline (PBS)–5% sucrose at either 16°C
(negative control for secretion) or 37°C. After 2 h of incubation, the cells were pelleted
and lysed to make whole-cell lysates (Wcl). The supernatant was passed through a
Vivaflow crossflow cassette using a 100-kDa molecular weight cutoff (MWCO) to
separate the heavier exosomes (Exo  100 kDa) from the lighter non-exosomal
secreted fraction (NESF  100 kDa). The level of NESF TvMIF was found to be 1.4-fold
higher than that of Exo TvMIF by immunoblotting using an anti-TvMIF antibody (4)
(Fig. 2B). As the Exo fraction had much less protein than the Wcl fraction and NESF from
equal numbers of cells, equal (20 g) amounts of protein were loaded in each fraction.
At 37°C, 20 g of protein is equal to 2.87% of the total NESF and 17.2% of the Exo
fraction. As a result, we can reason that approximately 8.4-fold-more TvMIF is secreted
in the NESF than in the Exo (17.2% divided by 2.87% and then multiplied by 1.4-fold).
FIG 1 TvMIF increases parasite survival under conditions of nutrient stress. (A) Overexpression of TvMIF in
the parasite enhances the survival of the parasite under conditions of serum starvation significantly after
8 h. All time points are normalized to time point 0 h for each parasite. Data are means  standard errors
of results from triplicates, and data from 1 of 3 independent experiments are shown. (B) Overexpression of
TvMIF enhances parasite resistance to density stress. The cultures started at a 1  e7/ml or 2  e7/ml
concentration and were incubated for 4 and 8 h. Data shown are means  standard errors of results from
triplicates, and data representative of 1 of 3 independent experiments are shown. *, P value  0.05; **,
P value  0.01; ***, P value  0.001.
FIG 2 TvMIF is present in the exosome and the non-exosomal secreted fractions. (A) A secretion assay used to determine
proportions of TvMIF in the exosome (Exo) and non-exosomal soluble fraction (NESF) is illustrated. Parasites were
incubated at either 16°C or 37°C. Incubation at 16°C is a negative control for secretion. After the incubation, the cells were
pelleted and lysed to become whole-cell lysates (Wcl) and the secreted supernatant fraction was passed through a Vivaflow
crossflow cassette to separate Exo from NESF. Then, the Exo was collected by ultracentrifugation. (B) At 16°C, no detectable
TvMIF was present in Exo and NESF. At 37°C, 1.4-fold more TvMIF was detected in the NESF than in the Exo fraction using
immunoblotting and a TvMIF antibody. Neomycin phosphotransferase (Neo) was used to detect cellular lysis.
Parasite Macrophage Migration Inhibitory Factor ®
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These data show that the majority of total secreted TvMIF is present as a soluble
protein.
Both intracellular TvMIF and secreted TvMIF are induced during serum star-
vation. As shown in Fig. 1, overexpression of TvMIF increased the survival of the
parasites during nutrient stress. Thus, we asked if induction of TvMIF expression and
its secretion play a role in the enhanced survival. First, to test if intracellular TvMIF
expression is induced under conditions of serum starvation, we collected the whole-cell
lysates (Wcl) from cells starved for 16 or 24 h and TvMIF levels were quantified by
immunoblotting. Intracellular TvMIF was found to be induced 1.6-fold at 16 h and
2.2-fold at 24 h after starvation (Fig. 3A and B). For determining TvMIF secretion levels
under conditions of serum starvation, parasites grown overnight in complete Dia-
mond’s media were collected, resuspended, and incubated in serum-free media for 3 h
or 6 h at 37°C. Cells were then spun, resuspended in PBS–5% sucrose, and incubated
for an additional 2 h at 37°C. Cells were then pelleted and lysed to make Wcl, and the
supernatant was collected to assess secretion. Immunoblot analyses showed that the
secreted TvMIF were induced ~2-fold and 2.5-fold higher from cells incubated in
serum-free media for 3 and 6 h, respectively, than from parasites grown in serum-
containing media (Fig. 3C). Neomycin phosphotransferase (Neo), a non-secreted pro-
tein, was used as a control to monitor cell lysis. The presence of Neo signal only in the
Wcl confirms that the TvMIF signal detected was the result of secretion and not cell
lysis.
Addition of recombinant MIFs increases survival of the parasite during serum
starvation. As survival and anti-apoptotic pathways are activated by huMIF in an
autocrine manner (15, 33, 34) and TvMIF secretion is induced during serum starvation
(Fig. 3), we generated recombinant MIF and added it to parasites to directly test
whether soluble TvMIF plays a role in enhancing parasite survival during serum
starvation. As shown in Fig. 4A, 50 ng/ml of recombinant TvMIF (rTvMIF) increased
FIG 3 Endogenous TvMIF protein is induced under conditions of serum starvation. (A) Anti-TvMIF
immunoblot showing that the TvMIF level was induced during serum starvation. Detection of GAPDH
served as the loading control. One representative immunoblot of three independent experiments is
shown. (B) Quantification of TvMIF was determined by normalizing the TvMIF signal to GAPDH for each
sample; the data were compared to the 0-h time point value (set at 1) in each experiment, so no error
bar was made for 0 h. Data are means standard errors. (C) TvMIF secretion was induced in the absence
of serum. Serum, cells grown in complete media; Serum, cells grown without serum. Secreted TvMIF
was induced ~2-fold at 3 h and ~2.5-fold at 6 h after serum starvation comparing serum and serum
signals. Neo was used as a negative control for cell lysis.
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parasite survival 1.2-fold at 4 h and 1.3-fold at 8 h after serum starvation. Human MIF
has been reported to be secreted during parasitic infection (35, 36). Thus, we tested
whether recombinant huMIF (rhuMIF) can also increase parasite survival. We found that
50 ng/ml of rhuMIF induced parasite survival 1.2-fold at 8 h (Fig. 4B). These results
support the idea of ability of the parasite to respond to both TvMIF and huMIF,
increasing parasite survival, and indicate that T. vaginalis can hijack huMIF to enhance
its survival.
Parasites overexpressing TvMIF can enhance survival of neighboring parasites
in co-cultures. Having established that secreted TvMIF is involved in signaling to
parasites, we next tested whether this occurs in an autocrine manner only or can
operate in trans. To test if secreted TvMIF can enhance the survival of neighboring
parasites, we set up a co-culture of EV and TvMIF-OE parasites in a transwell apparatus
using complete Diamond’s media. The bottom wells contained EV, and the top wells,
separated from the bottom wells by membranes with 0.4-m pores, contained either
EV or TvMIF-OE. Parasites in both the top and bottom wells were passaged into new
media daily for 7, 14, and 21 days (Fig. 5A) to maximize exposure of EV to abundant
TvMIF secreted from TvMIF-OE. Then, the cultures were switched to serum-free media
to induce nutrient stress and we measured the survival of the EV parasites in the
bottom wells under conditions of co-culture with either EV or TvMIF-OE parasites. We
found that EV parasites co-cultured with TvMIF-OE parasites for 7 days had a 1.4-fold-
higher survival rate than those co-cultured with EV control parasites, that those
co-cultured for 14 days had a 1.7-fold-higher survival rate, and that those co-cultured
for 21 days had a 2.3-fold-higher survival rate and that the survival advantage became
more dramatic with increasing numbers of days of co-culturing (Fig. 5B). These data
indicate that the abundance of TvMIF secretion from TvMIF-OE parasites enhanced the
survival of neighboring EV parasites, possibly exerting this effect via a positive-feedback
loop.
TvMIF inhibits parasite apoptosis. HuMIF is known to activate anti-apoptotic
pathways in human cells (14, 15, 37–39). To test whether TvMIF inhibits the apoptosis
of the parasites during serum starvation, we employed a double-staining method
similar to the commonly used annexin V and propidium iodide (PI) method (40) except
that we replaced PI with Zombie Red as the viability dye to exclude dead cells in the
FIG 4 Both recombinant TvMIF and recombinant huMIF increase the survival of the parasite under
conditions of serum starvation. (A) rTvMIF (50 ng/ml) or PBS (indicated as 0 ng/ml) was added to parasites
grown without serum at time point 0 h. rTvMIF at 50 ng/ml increased the parasite survival at both 4 h
and 8 h after serum starvation. (B) rhuMIF (50 ng/ml) or PBS (indicated as 0 ng/ml) was added to parasites
grown without serum at time point 0 h. rhuMIF at 50 ng/ml increased the parasite survival at 8 h after
starvation. Results of 3 independent experiments, each done in quadruplet, are represented by the data
shown here. Error bars represent means  standard errors. *, P value  0.05; **, P value  0.01.
Parasite Macrophage Migration Inhibitory Factor ®
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population. Annexin V, which labels externalized phosphatidylserine, is used as an
indicator of the number of parasites undergoing apoptosis (40). Using this assay, we
observed that EV parasites had slightly more apoptosis than TvMIF-OE parasites at 16 h
(P value  0.07). Moreover, after 24 h of serum starvation, EV parasites were signifi-
cantly more apoptotic than TvMIF-OE parasites (P value  0.01) (Fig. 6A). To further
FIG 5 Increased secretion of TvMIF by TvMIF-OE parasites increases survival of EV parasites after co-culture with TvMIF-OE parasites. (A) Scheme
of co-culture transwell assay. EV parasites in the wells indicated at the bottom were separated from EV or TvMIF-OE in the wells indicated at the
top by a membrane with 0.4-m pores. (B) Co-culturing EV parasites with TvMIF-OE parasites confers a survival advantage. EV parasites (bottom
well in Fig. 5A) were co-cultured with TvMIF-OE parasites (black bars) or EV parasites (white bars) for the number of days indicated on the x axis.
The EV parasites in the bottom well were then transferred to serum-free media for 24 h, and survival was measured. Error bars represent means
standard errors. *, P value  0.05; **, P value  0.01. The data represent results from 3 independent experiments, each done in triplicate.
FIG 6 TvMIF inhibits parasite apoptosis. (A) Double staining with annexin V and Zombie Red was used
to assess apoptosis. TvMIF-OE parasites (black bars) underwent less apoptosis at 16 h and 24 h after
serum starvation than EV parasites (white bars). MFI, mean fluorescence intensity; Healthy, DMSO-treated
control; STS, staurosporine (apoptosis inducer positive control). Error bars represent standard errors. *,
P value  0.05. (B) At 0 h, both EV and TvMIF-OE nuclei were intact with little damage. (C) Nuclei were
stained with DAPI. At 16 h after serum starvation, DNA damage in EV parasites was clearly visible. White
arrows indicate examples of DNA fragmentation. (D) DNA damage in EV parasites was significantly
greater than that observed in TvMIF-OE parasites after 16 h of serum starvation. The imaging data shown
in panels B and C were quantified by counting the number of fragmented DNA in a total of 300 nuclei
from both EV and TvMIF-OE parasites. *, P value  0.05. Error bars represent means  standard errors.
All data represent results from 3 independent triplicated experiments.
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validate the apoptotic phenotypes of the serum-starved parasites, we examined the
nuclei of EV and TvMIF-OE parasites grown in serum-free media for 16 h, as the nuclei
of T. vaginalis are reported to become condensed and fragmented when treated with
apoptosis inducers (24, 25). As shown in Fig. 6B and quantified in Fig. 6D, both EV and
TvMIF-OE parasites had low levels of DNA fragmentation at 0 h. In contrast, 16 h after
serum starvation, ~55% of EV parasites exhibited apoptotic-like DNA fragmentation,
whereas only ~38% of TvMIF-OE parasites displayed this phenotype (Fig. 6B to D).
These data demonstrate that TvMIF enhancement of parasite survival is associated with
a decrease in apoptosis. It is notable that the observed difference between TvMIF-OE
and EV parasites with respect to the anti-apoptotic phenotypes seen at 16 and 24 h is
not as dramatic as that observed for the survival phenotype (Fig. 1A), indicating that
other mechanisms may contribute to survival during serum starvation.
TvMIF inhibits parasite apoptosis during serum starvation via ROS suppres-
sion. Reactive oxygen species (ROS) activate apoptosis signaling in mammalian systems
(41), and huMIF is known to inhibit apoptosis by suppressing ROS production (42, 43).
To test whether TvMIF-induced survival under conditions of serum starvation is depen-
dent on ROS inhibition, we measured levels of superoxide, a known by-product of ROS
signaling, by staining EV and TvMIF-OE parasites with dihydroethidium (DHE). Upon
oxidization by superoxide, DHE is converted to fluorescent 2-hydroxyethidium (44) and
the intensity can then be used as a measure of ROS levels. We found that TvMIF-OE
parasites produced significantly less superoxide than EV parasites when grown without
serum for 16 or 24 h (Fig. 7A). To validate the specificity of the DHE signal, we treated EV
and TvMIF-OE parasites with the superoxide dismutase (SOD) mimetic manganese(III)
tetrakis(1-methyl-4-pyridyl)porphyrin (MnTmPyP) during serum starvation. MnTmPyP sig-
nificantly decreased the superoxide signal in EV parasites at both 250 M and 500 M
and in TvMIF-OE parasites at 500 M (Fig. 7B). The less dramatic effect that MnTmPyP
had on TvMIF-OE parasites is consistent with the ability of TvMIF-OE parasites to
suppress ROS production prior to the treatment. In addition, the survival of EV parasites
FIG 7 TvMIF inhibits parasite apoptosis under conditions of serum starvation via ROS suppression. (A) The
superoxide level detected by using dihydroethidium (DHE) was significantly higher at both 16 h and 24 h
in EV parasites than in TvMIF-OE parasites after serum starvation. MFI, mean fluorescence intensity. (B)
Superoxide dismutase (SOD) mimetic treatment at time point 0 h decreased the superoxide level in EV at
both 250 M and 500 M and in TvMIF-OE at 500 M. (C) SOD mimetic treatment increased EV parasite
survival at both 250 M and 500 M and TvMIF-OE parasite survival at 500 M. Ns, non-significant; *,
P value  0.05; **, P value  0.01; ***, P value  0.001. All data represent results from 3 independent
experiments, performed in triplicate.
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was strongly enhanced by MnTmPyP treatment, whereas TvMIF-OE parasite survival
was increased only slightly by the addition of 500 M MnTmPyP (Fig. 7C). The low
increase in survival of TvMIF-OE parasites resulted from normalizing the percentages of
living cells of treated TvMIF-OE and untreated TvMIF-OE parasites (Fig. 7C) as the
untreated TvMIF-OE parasites had higher survival rates than EV. Together, these data
indicate that inhibition of superoxide by TvMIF contributes to parasite survival under
conditions of serum starvation.
Gene knockout (KO) of TvMIF severely reduced parasite survival in serum-free
media. After completing the work described above, using TvMIF-OE and EV parasites
to study the role of TvMIF in parasite survival under nutrient stress, we succeeded in
developing CRISPR-Cas9 methods to knock out (KO) genes in T. vaginalis (4). These
methods allowed us to KO TvMIF in the parasite (4). As shown in Fig. 8A, immunoblot
analyses using the anti-TvMIF antibody confirmed that TvMIF was depleted in the
TvMIF KO parasites. To test whether the effects observed in comparisons of wild-type
and KO parasites were specific to the loss of TvMIF, we restored TvMIF to the KO
parasites (referred to here as 	addback parasites	) to test whether this rescued the KO
phenotype and caused reversion to that of the wild-type parasites. Immunoblot
analysis of addback parasites where TvMIF was overexpressed on a plasmid showed
that this resulted in greater expression of TvMIF than was observed in the wild-type
parasites (Fig. 8A). Testing the wild-type, TvMIF KO, and addback parasites for survival
under conditions of serum starvation, we found that TvMIF KO parasites had 16-fold
less and 9-fold less survival than the wild-type parasites and 23.7-fold and 27.7-fold less
survival than the addback parasites after 16 h and 24 h under conditions of serum
starvation, respectively (Fig. 8B). The increase in survival of addback parasites relative to
wild-type parasites is consistent with the higher levels of TvMIF expressed in addback
parasites, due to the gene’s presence on a multicopy plasmid. To further validate the
survival effect of TvMIF, we added rTvMIF to TvMIF KO parasites in serum-free media
and found that 100 ng/ml rTvMIF increased the survival 1.7-fold after 24 h, compared
to vehicle control (Fig. S4). Together, these results provide definitive evidence that
TvMIF plays a crucial role in resistance to death of the parasite under conditions of
nutrient stress.
DISCUSSION
We have established a role for TvMIF in the survival of the parasite under adverse
conditions. Although MIF has been widely studied in mammals, the function of this
conserved protein in other eukaryotes is largely unknown. We demonstrated that
overexpression of TvMIF increases parasite survival under conditions of nutrient star-
vation, which may be important for the parasite to maintain chronic infection in the
constantly changing vaginal environment (5). Nutrient starvation was also shown to
FIG 8 Parasites with the TvMIF gene knocked out have significantly less survival than the wild-type (WT)
parasites. (A) Immunoblot using anti-TvMIF antibody to confirm the loss of TvMIF in knockout (KO)
parasites and its presence in addback parasites. GAPDH is the loading control. (B) Knockout of TvMIF in
the parasite severely reduces the survival of the parasite under conditions of serum starvation. Adding
back of TvMIF in knockout parasites that exogenously overexpress the protein restores and enhances the
survival phenotype, reminiscent of the increased survival seen with TvMIF-OE. All time points are
normalized to time point 0 h for each parasite. Data are means  standard errors of results from
triplicates, and data from 1 of 3 independent experiments are shown. *, P value 0.05; **, P value 0.01;
***, P value  0.001.
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induce the expression and secretion of TvMIF by the parasite. By co-culturing parasites
that overexpress TvMIF (TvMIF-OE) with empty vector (EV) parasites that do not,
secreted TvMIF was shown to enhance the survival of EV parasites upon prolonged
co-culturing, suggesting the presence of an intracellular positive-feedback pathway by
which uptake of TvMIF triggers an increase in TvMIF expression and secretion. We were
ultimately able to knock out (KO) TvMIF and to show definitively that the loss of TvMIF
severely altered the ability of T. vaginalis to survive under conditions of nutrient stress.
We found that TvMIF inhibits parasite apoptosis during serum starvation, consistent
with the increased survival phenotype conferred on TvMIF-OE parasites. These data
imply that nutrient deprivation during infection induces parasite apoptotic pathways
and that increased production of TvMIF may allow the parasite to survive, awaiting
more favorable conditions within the urogenital tract. The ability of huMIF to inhibit
apoptosis and to contribute to oncogenesis is well established (15, 38, 45–48). This
functional conservation between huMIF and TvMIF is remarkable given their evolution-
ary divergence. Our findings are consistent with host-parasite interactions providing an
environment that allowed co-evolution of the two proteins.
Previous studies indicated that T. vaginalis undergoes apoptosis when treated with
drugs known to induce apoptosis in mammalian cells. Treatment with staurosporine
(STS) led to DNA condensation and staining with annexin V, both indicators of apo-
ptosis (24). The survival of T. vaginalis under conditions of iron depletion, glucose
restriction, or serum starvation has also been described, followed by examination of the
resulting differential gene expression (49–51). Re-evaluation of these data revealed that
under conditions of glucose restriction, TvMIF mRNA is upregulated by 3.8-fold at 12 h
and 1.3-fold at 24 h, indicating that TvMIF may be involved in enhancing parasite
survival under conditions of glucose starvation (50). In contrast, RNA analyses of
parasites grown under conditions of iron depletion revealed that TvMIF mRNA levels
were 2.5 times lower under iron-deficient conditions than under iron-rich conditions
(49). However, the time point used to extract RNA for the transcriptome sequencing
(RNA-seq) analysis was not stated. Therefore, it is possible that TvMIF was upregulated
to exert its survival effect at a different time during the analyses.
Although the studies on RNA regulation under glucose-deficient and iron-deficient
conditions (49, 50) provide insights into potential pathways that induce parasite
survival, prior to this study, no survival factor had been characterized or manipulated
by genetic approaches to directly address mechanisms underlying the survival pheno-
type. Our study results show that the induction of parasite survival by TvMIF via the
inhibition of apoptosis is accompanied by reactive oxygen species (ROS) suppression.
These data confirm the evolutionary conservation of apoptosis inhibition pathways, as
ROS has been shown to activate apoptosis signaling in mammalian systems (41) and
huMIF is known to inhibit apoptosis by suppressing ROS production (42, 43).
Induction of apoptosis in the parasitic protists Leishmania spp., Trypanosoma cruzi,
and Trypanosoma brucei is accompanied by an increase in ROS (52–57). However,
whether the modulation of apoptosis by MIF has been generally conserved between
protists and mammals, as appears to be the case for ROS, is yet to be determined. In
this regard, it is notable that the known roles of MIF in Xenopus laevis and Caenorhab-
ditis elegans are not directly related to survival under conditions of stress (58, 59). The
main functions of other parasite MIFs have been shown to be focused on their effects
on hosts. Leishmania major MIF (LmMIF), Plasmodium species MIF, Toxoplasma gondii
MIF, and Entamoeba histolytica MIF can bind huMIF receptor CD74 and modulate host
immune responses, activate huMIF pathways such as the extracellular signal-regulated
kinase/mitogen-activated protein kinase (ERK/MAPK) pathways, and affect the infection
outcome (10, 18, 20, 60, 61). LmMIF and Plasmodium yoelii MIF also inhibit apoptosis of
host macrophages by activating mammalian survival pathways (10, 61, 62). However,
the possible anti-apoptotic effect of parasite MIFs on these parasites is yet to be
examined.
We found that both TvMIF and huMIF confer cell survival, which may be the result
of host-parasite co-evolution. This notion is supported by our previous studies showing
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that TvMIF and huMIF induce the same signaling pathways in human cells, conferring
an anti-apoptotic and increased-growth phenotype (17), as well as by the data reported
here indicating that addition of rhuMIF induces parasite survival under conditions of
serum starvation. The latter observation implies that secreted huMIF could also directly
affect parasite survival under adverse conditions during infection.
TvMIF was originally identified in the T. vaginalis exosomal proteome (31). HuMIF is
also present in the exosomal proteome derived from a variety of human cell types
(63–71). The effect of huMIF on cell survival has been shown to be mostly focused on
soluble huMIF (14, 72, 73). However, Costa-Silva et al. showed that pancreatic ductal
adenocarcinoma-derived exosomes with abundant huMIF play a role in inducing liver
metastasis, although they did not test whether exosomal huMIF directly triggers
anti-apoptotic pathways (71). Further analyses will be required to determine whether
exosomal huMIF or TvMIF is capable of triggering anti-apoptotic pathways when
exosomes fuse and deliver their protein cargo into human and/or trichomonad cells.
Likewise, future transcriptomic and/or proteomic analyses should assist in identifying
the anti-apoptotic pathway(s) triggered by TvMIF.
MATERIALS AND METHODS
T. vaginalis cell culture and transfection. T. vaginalis strain B7RC2 (ATCC 50167) was cultured in
Diamond’s medium supplemented with 100 U/ml penicillin and 100 g/ml streptomycin (Thermo Fisher
Scientific), 180 M ferrous ammonium sulfate (Fisher), 28 M sulfosalicylic acid (Fisher), and 10% horse
serum (Sigma) (complete Diamond’s media) (26). TVAG_219770 (TvMIF) was overexpressed in Master-
Neo-(HA [hemagglutinin])2 plasmid and transfected as previously described (17). The plasmid was
maintained with 100 g/ml of G418 (Gibco) for selection. Parasites were cultured at 37°C and passaged
daily for 2 weeks or less.
Serum starvation assay. T. vaginalis was cultured overnight in complete Diamond’s media (26). The
parasites were then pelleted by centrifugation and resuspended at 106 cells/ml in the same media, with
the exception that no horse serum was added (serum-free Diamond’s media), and incubated at 37°C at
the time points indicated. At each time point, 500 l of culture was taken from each sample and read
on a FACS instrument. The survival rates of the parasites were determined by excluding dead cells using
Zombie Red viability dye at a 1:1,000 dilution in PBS (BioLegend) and quantitated using CountBright
Absolute Counting Beads (Thermo Fisher Scientific) with a BD LSRFortessa cell analyzer (see Fig. S2 in the
supplemental material). The percentages of living cells at all of the time points were normalized to the
level at time point 0 h, which was set as 100%.
Density stress assay. EV and TvMIF-OE parasites were grown to mid-log phase (106 cells/ml)
overnight and concentrated to 107 cells/ml or 2  107 cells/ml in complete Diamond’s media. These
parasites were then incubated for 4 h or 8 h. The cells were subjected to FACS analyses using a BD
LSRFortessa cell analyzer. The percentages of dead cells were determined by gating the Zombie
Red-positive population and determining its percentage relative to the total cell population.
Growth assay. EV and TvMIF-OE parasites (4  104 cells/ml) were cultured in complete Diamond’s
media. At 12 h and 24 h, 500 l of each sample was taken for FACS analyses to determine the numbers
of living cells. Numbers of living cells were determined as described for the serum starvation assay.
Secretion assay. The parasites were grown to mid-log phase overnight in complete Diamond’s
media, collected, and resuspended in PBS–5% sucrose at 106 cells/ml. The parasites (5  108) were
incubated at either 16°C or 37°C for 2 h. The 16°C condition was used for the secretion inhibition control.
After the incubation, the parasites were spun at 3,200 rpm for 10 min and the cell pellets were collected
and lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 2% SDS, and 1 Halt protease inhibitor
cocktail (Thermo Fisher Scientific) to make whole-cell lysates (Wcl). The supernatant was passed through
a PES Vivaflow crossflow cassette (Sartorious) (MWCO, 100 kDa) to separate the exosomes (Exo) from the
non-exosomal soluble fraction (NESF). The NESF was concentrated by using Amicon Ultra Centrifugal
filters (EMD Millipore) (MWCO, 10 K). The Exo were pelleted at 100,000  g for 70 min. Anti-neomycin
phosphotransferase (Neo) (Jackson Laboratory) (1:2,500) and anti-TvMIF antibodies (polyclonal rabbit
antisera raised against TvMIF) (1:500) (4) were used as the primary antibodies and anti-rabbit antibody
(Jackson Laboratory) (1:25,000) was used as the secondary antibody for both Neo and TvMIF probing.
Intracellular and secreted TvMIF quantitation. Anti-TvMIF polyclonal antibody, anti-glyceraldehyde
3-phosphate dehydrogenase (anti-GAPDH) antibody (Cocalico Biologicals) (1:10,000), and anti-Neo anti-
body (Jackson Laboratory) (1:2,500) were used as the primary antibodies, and anti-rabbit (Jackson
Laboratory) was used as the secondary antibody. For intracellular TvMIF quantitation, mid-log-phase
parasites were spun down and washed with PBS–5% sucrose–1 Halt protease inhibitor cocktail (Thermo
Fisher Scientific). The cells were then lysed in 50 mM Tris-HCl (pH 7.5)–2% SDS–1 Halt protease inhibitor
cocktail lysis buffer. Equal total proteins were loaded from whole-cell lysates from 0 h, 16 h, and 24 h.
For secreted TvMIF quantitation, T. vaginalis parasites cultured overnight in complete Diamond’s media
were collected and resuspended in serum-free or complete Diamond’s media for 3 h or 6 h of incubation.
After the incubation, the parasites were resuspended in PBS–5% sucrose for 2 h of incubation for
secretion collection. The cells were spun down and collected using the method described for intracellular
TvMIF quantitation as the whole-cell lysate (Wcl) control. The supernatant was then concentrated with
Chen et al. ®
May/June 2018 Volume 9 Issue 3 e00910-18 mbio.asm.org 10
Amicon Ultra Centrifugal Filters (MWCO  10 K). Equal total protein amounts were loaded for the Wcl
control and secreted fractions for all samples.
Production and purification of rTvMIF and rhuMIF. TvMIF and huMIF was cloned into the pET
SUMO expression vector with an N-terminal SUMO domain with 6His tag separately. Both constructs
were transformed into BL21(DE3) E. coli (Thermo Fisher Scientific) for protein expression (74). rTvMIF and
rhuMIF were purified using a HisPur nickel-nitrilotriacetic acid (Ni-NTA) Spin column (Thermo Fisher
Scientific) and dialyzed into 20 mM Tris-HCl (pH 8.0)–150 mM NaCl–1 mM dithiothreitol (DTT). His-tagged
SUMO protease (mclab) in combination with SUMO protease buffer (50 mM Tris (pH 8.0), 1 mM DTT) was
used to cleave off N-terminal SUMO and the 6His tag to produce rTvMIF and rhuMIF with their native
sequences. SUMO protease and the SUMO domain with the His tag were removed by the use of a HisPur
Ni-NTA Spin column. rTvMIF and rhuMIF were then purified by the use of Econo-Pac 10DG desalting
prepacked gravity flow columns (Bio-Rad).
Exogenous rTvMIF and rhuMIF addition and survival assay. A 50 ng/ml volume of rTvMIF or
rhuMIF or PBS vehicle control was added to TvMIF-OE grown in serum-free Diamond’s media. The
survival rates were determined 4 h and 8 h after starvation. rTvMIF (100 ng/ml) or PBS vehicle was added
to TvMIF KO parasites in serum-free Diamond’s media. The survival rates were determined 24 h after
starvation.
Co-culture in transwell. Transwell (Corning) with a 0.4-m-pore-size polycarbonate membrane
insert was used. EV or TvMIF-OE (1.8  105) was plated in 300 l of complete Diamond’s media in each
individual top insert, and EV (2  105) was plated in 1 ml of media in each individual bottom well. The
top and bottom cells were passaged and rediluted daily to the concentrations described above in
complete Diamond’s media. Every 7 days, the cells were resuspended in serum-free Diamond’s media at
the concentration described above and incubated for 24 h for survival tests. The survival rates were
determined as described for the serum starvation assays.
Apoptosis assays. Zombie Red (1:1,000) and 4.5 g/ml of fluorescein isothiocyanate (FITC)-annexin
V (BioLegend) in annexin V binding buffer (BioLegend) were used to stain parasites grown without serum
at 0 h, 16 h, and 24 h, and the cells were subjected to FACS analysis using a BD LSRFortessa cell analyzer.
The live parasites were gated by excluding positive Zombie Red signal. Apoptotic levels were determined
by analysis of the mean fluorescence intensity (MFI) of annexin V of live parasites. Parasites treated with
dimethyl sulfoxide (DMSO) were used as the healthy control, and parasites treated with 4 M stauro-
sporine (STS) for 16 h composed the apoptotic control.
DNA fragmentation was done by incubating EV and TvMIF-OE in serum-free Diamond’s media and
fixing parasites in 4% formaldehyde–PBS. Parasite nuclei were stained with ProLong Gold antifade
mountant with 4=,6-diamidino-2-pheylindole (DAPI) (Thermo Fisher Scientific). The slides were then
imaged using an Axioskop 2 epifluorescence microscope (Zeiss). The percentage of fragmented DNA was
determined by the number of fragmented DNA in a total of 300 nuclei counted in each sample by using
ZEN lite software.
Reactive oxygen species (ROS) detection and superoxide dismutase (SOD) mimetic treatment.
EV and TvMIF-OE parasites were grown in serum-free Diamond’s media as previously described. At 0 h,
16 h, and 24 h, cells were stained with 2 M dihydroethidium (DHE) (Thermo Fisher Scientific) mixed with
PBS at 37°C for 30 min in the dark. The MFI of ROS signal was determined by the MFI of phycoerythrin-
Texas Red (PE-Texas Red)-treated live cells gated by the use of a flow cytometer.
For SOD mimetic treatment, a 250 M or 500 M concentration of manganese(III) tetrakis(1-methyl-
4-pyridyl)porphyrin (MnTmPyP) (Sigma) or DMSO was used to treat parasites grown in serum-free
Diamond’s media at time point 0 h. At 16 h, parasites were stained with DHE and CountBright absolute
counting beads (Thermo Fisher Scientific) were added to determine the number of live cells. The ROS
signal and the percentage of living cells were measured by the use of a flow cytometer.
Gene knockout and adding back of TvMIF in T. vaginalis B7RC2. The constructs and reagents
used to create the TvMIF knockout were as described by Janssen et al. (4). Adding back of TvMIF to TvMIF
KO cells was done by transfection of TVAG_219770 (TvMIF) in Master-Neo-(HA)2 plasmid with selection
of G418 at the concentration of 900 g/ml in order to select for the plasmid in the presence of a
neomycin phosphotransferase (Neo) gene knock-in at the TvMIF gene locus, replacing the TvMIF gene.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
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